Skip to main content

P21 vs CJC-1295

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

P21

P21 is a synthetic peptide derived from Cerebrolysin, specifically designed to mimic the neurotrophic effects of the parent compound. It promotes neurogenesis and has shown cognitive-enhancing properties in research.

Full details →

CJC-1295

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce more growth hormone.

Full details →

Side-by-Side Comparison

AspectP21CJC-1295
MechanismInhibits glycogen synthase kinase-3β (GSK-3β) and activates CREB signaling pathway. This promotes BDNF expression, neurogenesis in the hippocampus, and synaptic plasticity.CJC-1295 binds to GHRH receptors in the pituitary, triggering increased production and release of growth hormone. The DAC (Drug Affinity Complex) version extends half-life significantly.
Typical DosageResearch protocols typically use 1-5mg administered intranasally or subcutaneously. Often used in cycles of 2-4 weeks.CJC-1295 DAC: 1-2mg weekly. CJC-1295 no DAC (Mod GRF 1-29): 100-300mcg 2-3 times daily.
AdministrationCan be administered intranasally for direct CNS access or subcutaneously. Best used cyclically rather than continuously.Subcutaneous injection, often combined with a GHRP like Ipamorelin for synergistic effects. Best administered before sleep or fasted.
Side EffectsLimited data. Reported effects include mild headache, temporary brain fog during initial use, and fatigue.Water retention, tingling in extremities, potential increase in cortisol and prolactin levels.
Best For

Key Differences

Detailed Analysis

CJC-1295 and P21 are used for different purposes and have limited overlap in their applications.

Which Should You Choose?

Choose CJC-1295 for Muscle Growth, Fat Loss, Sleep Quality. Choose P21 for Cognitive Performance.

Ready to Learn More?